Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins
Hervé Broly(Merck Serono S.A. (Switzerland)), Alain Beck(Centro de Investigacion Principe Felipe)
Cited by 5
Related Papers
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772